BSE Live
Oct 17, 16:01Prev. Close
20.70
Open Price
21.02
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Balance Sheet of Bharat Immunologicals and Biologicals Corporation (in Rs. Cr.) | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | |
Total Share Capital | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | |
Reserves and Surplus | -5.68 | -1.43 | -8.07 | -1.87 | -3.41 | |
Total Reserves and Surplus | -5.68 | -1.43 | -8.07 | -1.87 | -3.41 | |
Total Shareholders Funds | 37.50 | 41.75 | 35.11 | 41.31 | 39.77 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.28 | 0.00 | |
Other Long Term Liabilities | 0.00 | 0.00 | 0.36 | 0.24 | 0.24 | |
Long Term Provisions | 3.38 | 3.01 | 3.04 | 3.08 | 2.76 | |
Total Non-Current Liabilities | 3.38 | 3.01 | 3.41 | 3.60 | 2.99 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.06 | 9.42 | -8.84 | 0.00 | |
Trade Payables | 0.42 | 0.29 | 7.71 | 31.26 | 31.99 | |
Other Current Liabilities | 11.38 | 13.57 | 12.61 | 12.38 | 7.08 | |
Short Term Provisions | 0.73 | 0.21 | 0.13 | 0.54 | 2.48 | |
Total Current Liabilities | 12.53 | 14.13 | 29.87 | 35.35 | 41.55 | |
Total Capital And Liabilities | 53.40 | 58.90 | 68.38 | 80.26 | 92.20 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 4.95 | 5.36 | 5.50 | 6.05 | 6.76 | |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Work-In-Progress | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 5.17 | 5.58 | 5.72 | 6.27 | 6.98 | |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 7.93 | 4.24 | 2.47 | 0.00 | 0.14 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.43 | 0.40 | 0.40 | |
Other Non-Current Assets | 2.10 | 2.29 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Assets | 15.20 | 12.11 | 8.61 | 6.67 | 7.53 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 1.72 | 0.37 | 22.47 | 25.65 | 29.89 | |
Trade Receivables | 15.94 | 6.45 | 13.08 | 13.70 | 26.20 | |
Cash And Cash Equivalents | 20.00 | 39.05 | 20.14 | 30.26 | 24.51 | |
Short Term Loans And Advances | 0.00 | 0.00 | 3.63 | 3.65 | 3.48 | |
OtherCurrentAssets | 0.53 | 0.91 | 0.45 | 0.33 | 0.60 | |
Total Current Assets | 38.20 | 46.79 | 59.77 | 73.59 | 84.67 | |
Total Assets | 53.40 | 58.90 | 68.38 | 80.26 | 92.20 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 3.96 | 4.35 | 14.65 | 38.09 | 38.67 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 28.03 | 79.41 | 0.00 | 0.01 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
05.06.2023
Bharat Immuno Standalone March 2023 Net Sales at Rs 7.65 crore, down 65.29% Y-o-Y
25.08.2022
Bharat Immuno Standalone June 2022 Net Sales at Rs 10.48 crore, down 26.28% Y-o-Y
01.06.2022
Bharat Immuno Standalone March 2022 Net Sales at Rs 22.04 crore, up 41.07% Y-o-Y
09.02.2022
Bharat Immuno Standalone December 2021 Net Sales at Rs 17.43 crore, down 30.83% Y-o-Y
05.06.2023
Bharat Immuno Standalone March 2023 Net Sales at Rs 7.65 crore, down 65.29% Y-o-Y
25.08.2022
Bharat Immuno Standalone June 2022 Net Sales at Rs 10.48 crore, down 26.28% Y-o-Y
01.06.2022
Bharat Immuno Standalone March 2022 Net Sales at Rs 22.04 crore, up 41.07% Y-o-Y
09.02.2022
Bharat Immuno Standalone December 2021 Net Sales at Rs 17.43 crore, down 30.83% Y-o-Y